| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ... Science 350 (6264), 1079-1084, 2015 | 3120 | 2015 |
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide S Viaud, F Saccheri, G Mignot, T Yamazaki, R Daillère, D Hannani, ... science 342 (6161), 971-976, 2013 | 1969 | 2013 |
| Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ... Nature medicine 20 (11), 1301-1309, 2014 | 1045 | 2014 |
| Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects R Daillère, M Vétizou, N Waldschmitt, T Yamazaki, C Isnard, ... Immunity 45 (4), 931-943, 2016 | 763 | 2016 |
| Caloric restriction mimetics enhance anticancer immunosurveillance F Pietrocola, J Pol, E Vacchelli, S Rao, DP Enot, EE Baracco, S Levesque, ... Cancer cell 30 (1), 147-160, 2016 | 501 | 2016 |
| Regulation of autophagy by cytosolic acetyl-coenzyme A G Mariño, F Pietrocola, T Eisenberg, Y Kong, SA Malik, A Andryushkova, ... Molecular cell 53 (5), 710-725, 2014 | 488 | 2014 |
| Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops GS Catchpole, M Beckmann, DP Enot, M Mondhe, B Zywicki, J Taylor, ... Proceedings of the National Academy of Sciences of the United States of …, 2005 | 467 | 2005 |
| Targeted metabolomics for biomarker discovery WJ Griffiths, T Koal, Y Wang, M Kohl, DP Enot, HP Deigner Angewandte Chemie International Edition 49 (32), 5426-5445, 2010 | 448 | 2010 |
| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ... Science 350 (6263), 972-978, 2015 | 438 | 2015 |
| Programmed mitophagy is essential for the glycolytic switch during cell differentiation L Esteban‐Martínez, E Sierra‐Filardi, RS McGreal, M Salazar‐Roa, ... The EMBO journal 36 (12), 1688-1706, 2017 | 288 | 2017 |
| Spermidine induces autophagy by inhibiting the acetyltransferase EP300 F Pietrocola, S Lachkar, DP Enot, M Niso-Santano, BS Pedro, V Sica, ... Cell Death & Differentiation 22 (3), 509-516, 2015 | 282 | 2015 |
| Metabolomic analysis reveals a common pattern of metabolic re‐programming during invasion of three host plant species by Magnaporthe grisea D Parker, M Beckmann, H Zubair, DP Enot, Z Caracuel‐Rios, DP Overy, ... The Plant Journal 59 (5), 723-737, 2009 | 259 | 2009 |
| A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1 SF Ngiow, A Young, N Jacquelot, T Yamazaki, D Enot, L Zitvogel, ... Cancer research 75 (18), 3800-3811, 2015 | 248 | 2015 |
| Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ... Cell research 29 (10), 846-861, 2019 | 199 | 2019 |
| Predictors of responses to immune checkpoint blockade in advanced melanoma N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ... Nature communications 8 (1), 592, 2017 | 194 | 2017 |
| Metabolite signal identification in accurate mass metabolomics data with MZedDB, an interactive m/z annotation tool utilising predicted ionisation behaviour'rules' J Draper, D Enot, D Parker, M Beckmann, S Snowdon, W Lin, H Zubair BMC bioinformatics 10 (1), 227, 2009 | 185 | 2009 |
| Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 D Hannani, M Vétizou, D Enot, S Rusakiewicz, N Chaput, D Klatzmann, ... Cell research 25 (2), 208-224, 2015 | 184 | 2015 |
| Cisplatin resistance associated with PARP hyperactivation J Michels, I Vitale, L Galluzzi, J Adam, KA Olaussen, O Kepp, L Senovilla, ... Cancer research 73 (7), 2271-2280, 2013 | 183 | 2013 |
| Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients M Semeraro, S Rusakiewicz, V Minard-Colin, NF Delahaye, D Enot, ... Science translational medicine 7 (283), 283ra55-283ra55, 2015 | 153 | 2015 |
| High-throughput, nontargeted metabolite fingerprinting using nominal mass flow injection electrospray mass spectrometry M Beckmann, D Parker, DP Enot, E Duval, J Draper Nature protocols 3 (3), 486-504, 2008 | 153 | 2008 |
